Fact CheckerSign in

NCT07171437Not yet recruiting

Assessment of GIT Vasculopathy in SSc and Its Multisystem Correlations

Assessment of Gastrointestinal Vasculopathy in Systemic Sclerosis and Its Multisystem Correlations

Source: ClinicalTrials.gov · Last updated 12 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

* Evaluation of splanchnic vasculature, including arterial blood flow using Doppler ultrasound in patients with systemic sclerosis compared to healthy subjects. * Correlation of Doppler findings of splanchnic vessels with GIT manifestations. * Correlation of Doppler findings of splanchnic vessels with macrovascular affection (chest, cardiac, and renal), microvascular involvement (capillaroscopy findings), and autoantibodies (anti-SCL70 antibody and anti-centromere antibody).

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
74 (estimated)
First submitted
6 Sept 2025
Start date
1 Oct 2025
Primary completion date
Oct 2026
Lead sponsor
Esraa Moustafa Mohammed
NCT number
NCT07171437

What you commit to

  • Study type: Observational
  • Planned participants: 74
  • From 1 Oct 2025 to the primary completion date, Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with overlapping autoimmune diseases (e.g., lupus, rheumatoid arthritis).
  • Patients with known gastrointestinal disorders not related to systemic sclerosis (e.g., inflammatory bowel disease, celiac disease).
  • Patients with a history of major gastrointestinal surgery (e.g., bowel resection).
  • Patients with diabetes mellitus (due to its independent effects on vascular flow).
  • Presence of severe comorbidities (e.g., end-stage renal disease, decompensated heart failure).

Age

  • Patients younger than 18 years old.

Other

  • Pregnancy or lactation.

Who the study is looking for

  • Adult patients aged 18 years or older.
  • Patients classified as systemic sclerosis (SSc) according to ACR/EULAR 2013 classification criteria.
  • Patients who consented to undergo Doppler ultrasound (DUS) assessment of the splanchnic vessels.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Assiut University, Assiut, 71111
Coordinator of this site? Confirm its status
AsyutEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.